This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The UK 100 index trades fresh highs getting a boost from worse-than-expected first quarter UK GDP growth (construction weak, bad weather) which adds to weak UK inflation and Wage growth, as well as surprisingly dovish commentary from Bank of England Governor Carney. This has resulted in a near-evaporation in expectations for a UK interest rate hike in May (22% probability vs 96% just two weeks ago). The 1%+ drop for GBP, vs both USD and EUR, however, is a silver lining for equity traders, flattering the value of UK blue-chips’ international profits and dividends, helping their share prices higher.
Contributors: UK Index +50pts, with the biggest positive contributions from RDSB, (still high oil price, weaker GBP), ULVR/BATS/DGE/RB/IMB (weaker GBP), HSBC(breakout, results next week), AZN/GSK (rebound), AZN (drug news). The major drag today comes from RBS (Q1 results), BHP/GLEN (stronger USD hindrance on metals offsetting benefit of weaker GBP, slowest China industrial profits growth in 21 months) and LLOY (RBS read-across).
Technicals: The UK 100 extends its breakout from 7400, extending its retrace of the ground lost late-Jan/early-Feb from 2018’s 7800 record highs. Three-month Bullish inverse head and shoulders reversal in motion?
Click below to expand sections for more detailed analysis
The UK Index 100 extends its breakout from 7400, extending its retrace of the ground lost late-Jan/early-Feb from 2018’s 7800 record highs. Three-month Bullish inverse head and shoulders reversal?
Watch levels: Bullish 7500, Bearish 7470
Solid Green line
Possible support
Solid Red line
Possible resistance
Important: The information provided above does not constitute advice or opinion and must only be regarded as technical observations.
Click here for help with Support & Resistance Click here for help with technicals
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research